Because many receptor proteins (e.g., EGFR, PDGFRA, PDGFRB, ERBB2, and ERBB4) are typically located in the upstream of cancer-related signaling pathways such as proliferation, cell death, and cell cycle progression [9], mutations in these genes are likely critical to cancer development. The gene discussed is ERBB4; the disease is cancer.